Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Coherus
FDA Approves YUSIMRY — Coherus BioSciences Inc

On December 17, 2021, the FDA approved Coherus BioSciences' commercial footprint by granting accelerated approval for YUSIMRY (adalimumab-aqvH), the r...

Heritage
FDA Approves METFORMIN HYDROCHLORIDE — Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. has received FDA approval for the ANDA213320, marking the approval of oral Metformin Hyd...

Biocon
FDA Approves MYCOPHENOLIC ACID — Biocon Pharma Inc.

Biocon Pharma Inc. announced the FDA approval of its generic version of Mycophenolate Sodium for Oral Suspension, marking a strategic expansion in its...

AADI
FDA Approves Unknown Drug — AADI

AADI has announced the FDA approval of its undisclosed product, expected to have potentially significant market implications given the undisclosed pha...

PharmaEssentia
FDA Approves BESREMI — PharmaEssentia USA

PharmaEssentia USA has secured FDA approval under BLA761166 for BESREMI (ropeginterferon alfa-2b) to treat adult polycythemia vera, marking a strategi...

Azurity
FDA Approves EPRONTIA — Azurity Pharmaceuticals, Inc.

# FDA Approves Azurity Pharmaceuticals' EPRONTIA (Topiramate) for Oral Administration Azurity Pharmaceuticals, Inc. has received FDA approval for EPR...

Amneal
FDA Approves MYCOPHENOLATE MOFETIL — Amneal Pharmaceuticals LLC

Amneal Pharmaceuticals has received U.S. FDA approval for the generic version of mycophenolate mofetil, positioning the company to compete head-to-hea...

Dr.
FDA Approves LENALIDOMIDE — Dr. Reddy's Laboratories Inc.

# FDA Approves Dr. Reddy's Laboratories Generic Lenalidomide Dr. Reddy's Laboratories Inc. received FDA approval for its generic version of lenalidom...

Ascend
FDA Approves MYCOPHENOLIC ACID — Ascend Laboratories, LLC

The FDA has granted approval to Ascend Laboratories for its ANDA (ANDA208315) marketing application for Mycophenolic Acid, a generic tablets offering ...

INGENUS
FDA Approves BUPRENORPHINE — INGENUS PHARMACEUTICALS, LLC

Ingenus Pharmaceuticals received FDA approval for the transdermal buprenorphine ANDA, a move that potentially disrupts the Integrated Pain Therapeutic...

Incyte
FDA Approves OPZELURA — Incyte Corporation

Ivy.ai is an AI-powered financial news platform. Incyte Corporation has announced the approval of their topical JAK inhibitor ruxolitinib phosphate (O...

Upsher-Smith
FDA Approves ISOTRETINOIN — Upsher-Smith Laboratories, LLC

Upsher-Smith Laboratories announced today that the FDA has granted final approval to its Abbreviated New Drug Application (ANDA) for generic isotretin...

BIOGEN
FDA Approves BYOOVIZ — BIOGEN INC.

Biogen received U.S. regulatory approval on September 17, 2021, to market a biosimilar version of the blockbuster wet AMD treatment ranibizumab. This ...

Alembic
FDA Approves METRONIDAZOLE — Alembic Pharmaceuticals Limited

# FDA Approves Alembic Pharmaceuticals' Generic Metronidazole Topical Formulation The U.S. Food and Drug Administration has approved Alembic Pharmace...

SANKALP
FDA Approves Unknown Drug — SANKALP LIFECARE

Sankalp Lifecare secured FDA approval for its ANDA in August 2021, a milestone expected to bolster its portfolio and signal potential revenue expansio...

Torrent
FDA Approves LURASIDONE HYDROCHLORIDE — Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals Limited announced that the FDA has approved its ANDA for lurasidone hydrochloride oral tablets, broadening its portfolio of an...

NorthStar
FDA Approves LEUPROLIDE ACETATE — NorthStar RxLLC

# FDA Approves NorthStar RxLLC's Generic Leuprolide Acetate Injection NorthStar RxLLC received FDA approval for its generic leuprolide acetate subcut...

Merck
FDA Approves WELIREG — Merck Sharp & Dohme LLC

Merck Sharp & Dohme LLC received FDA approval for its belzutifan tablets (WELIREG) to treat about half of individuals with von Hippel-Lindau disease, ...

Ascend
FDA Approves IBUPROFEN AND FAMOTIDINE — Ascend Laboratories, LLC

Ascend Laboratories has received FDA approval for the generic combination drug ibuprofen and famotidine, placing it in direct competition with branded...

Actelion
FDA Approves UPTRAVI — Actelion Pharmaceuticals US, Inc.

Actelion Pharmaceuticals US, Inc. secured FDA approval for the intravenous administration of UPTRAVI (selexipag) under NDA 214275 on July 29, 2021, a ...